| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ras protein specific guanine nucleotide releasing factor 2 | 0.644 | 0.615 | 0.15 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
retinoic acid receptor responder 2 | 0.519 | 0.731 | 2.7E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
nuclear factor I X | 0.547 | 0.769 | 1.00 |
|
disease | 0.420 | None | 1.000 | 1 | 1 | 2013 | 2018 | ||||||||
|
retinoid X receptor gamma | 0.674 | 0.615 | 0.42 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
DEP domain containing MTOR interacting protein | 0.626 | 0.654 | 3.7E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
GRB10 interacting GYF protein 1 | 0.751 | 0.269 | 3.4E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
LHFPL3 antisense RNA 1 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 461 | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
arginine-glutamic acid dipeptide repeats | 0.526 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
nuclear factor I A | 0.599 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 7 | 2013 | 2013 | ||||||||
|
family with sequence similarity 178 member B | 0.931 | 0.038 | 8.2E-13 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ribokinase | 0.890 | 0.077 | 5.2E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
6-pyruvoyltetrahydropterin synthase | 0.636 | 0.654 | 6.5E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
protein tyrosine phosphatase receptor type G | 0.619 | 0.731 | 5.1E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
WD repeat domain 12 | 0.769 | 0.192 | 3.3E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
renalase, FAD dependent amine oxidase | 0.678 | 0.423 | 3.8E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
membrane palmitoylated protein 6 | 0.821 | 0.077 | 0.82 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
Rho guanine nucleotide exchange factor 10 like | 0.792 | 0.192 | 4.7E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
zinc finger CCHC-type containing 2 | 0.805 | 0.308 | 0.99 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
cyclin and CBS domain divalent metal cation transport mediator 2 | 0.641 | 0.346 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2013 | 2015 | ||||||||
|
phospholipase C beta 4 | 0.610 | 0.731 | 3.0E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | 0.633 | 0.692 | 1.0E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
ankyrin repeat and sterile alpha motif domain containing 1B | 0.686 | 0.423 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
phosphodiesterase 3B | 0.659 | 0.577 | 5.7E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |